in fact, gw pharma is down 40% from its highs even though it's in great shape and reported two fantasticrters and the u.s.' launch of their drug is a success and got approval in europe the stock down another 8%. weighed down by the cannabis etfs and cannabis companies we follow i think you might be getting a remarkable buy opportunity let's check in with the ceo of the company with a better read welcome back to "mad money." >> thank you, jim. thank you for having me back. >> justin, given the size of the european market because i have to believe if it's anything like the american market you will have a lot of success here >> yes, well, just yesterday as your introduction mentioned we reached another historic milestone for the company, for patients and for the field of cannabinoid science. we have 28 countries in europe that approved end pidilex and market of 500 million people and had a great experience of launching it in the united states and really i think the company is in the best shape it's ever been. >> that's what i wanted to ask you about. the wall street estimate were so low. do

now, not gw pharma but broad given the fed more reason to cut rates and if you want to know how the cpi could be low, just listen on croaker's conference call the supermarket chain cannot raise prices to save its life. why? the world is dominated by, yes, costco and amazon and target and walmart. these huge players doing everything they can to keep grocery prices down and succeeding because that's how they edge out the competition. no wonder kroger stock is wallowing. we hear from one controversial stock that is just one of my favs and it's broadcom this might be the most important earnings call of the week, why first they do a huge amount of business in china. second, supposed to be the punitive buyer of the enterprise portion of the cybersecurity company semantec. let's see what developens thes and the business, too, the ceo is tough and boy, does he like to buy his stock back? i bet he delivers a terrific quarter. retail sales, the incredible decline of the mall which is captured in the overall retail numbers and growth of the e commercom -- e commerce numbers when we interviewed my

pharma? >> because we had bad players. we really have to do something harder about this than what we currently are. >> gw is hoping to developthing from anxiety to autism and many others are trying, as well. >> that's what we want, cbd for fda as a medicine. >> mount sinai's dr. yazmin heard has been developing cbd products to address one of the most concerning issues of our time, the opioid endem hipidemi >> you think cbd can be the tool? >> yes. >> do i think it's a wonder drug? no. do i i think it can alleviate certain disorders? absolutely. that's why we need to find out. >> through research. which for years had been near impossible. >> the farm bill now allows us to work with hemp-devooifrived that's helpful or we would never be able to conduct the large clinical trials that are needed. >> now there's a whole new wave of cbd research that is being funded. >> the stanley brothers are among them. while proof that cannabis works isn't yet required for cbd to be sold in stores or online, they want the data regardless. >> we live in a world, in a system that needs scientific validation and a process before you can make any c